Alternatives to Ella Therapeutics

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Develops, manufactures, and markets radiopharmaceuticals for diagnostic and therapeutic applications.

Global biopharmaceutical company focused on oncology and neuroscience treatments.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered blood test for early cancer detection and subtyping.

Omnix Medical is developing a novel platform for advanced wound care management.

Develops a platform for individual drug customization using aptamers for cancer treatment.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Cloud-based platform for reproducible computational research in life sciences.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases.

Developing a novel small molecule inhibitor for ovarian cancer treatment targeting DIO3.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.